Regentis Biomaterials Withdraws F-1 Registration Statement And Cancels Planned Public Offering

Benzinga Newsdesk www.benzinga.com Neutral 93.1%

Neg 0% Neu 93.1% Pos 0%

https://www.sec.gov/Archives/edgar/data/1912966/000121390026068601/ea0294796-6k_regentis.htm

Comments

No comments yet. Be the first!